- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07721701
Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers (digiDEM Bayern)
Digital Dementia Registry Bavaria (digiDEM Bayern)
Around 57 million people worldwide live with dementia, with approximately 10 million new cases diagnosed each year. By the end of 2023, around 1.8 million people were living with dementia in Germany, the majority of whom were over 65 years of age (1.7 million). In Bavaria, around 257,000 people were living with dementia in 2023. Providing care and support for these people in the future is one of the biggest challenges not only for the healthcare system, but also for society as a whole. This is particularly true when it comes to caring for people with dementia in rural areas.
The Digital Dementia Registry Bavaria (digiDEM Bayern) is a health outcomes research project that aims to improve understanding of the clinical complexity, long-term progression, and care situation of dementia.
digiDEM Bayern is a multicenter longitudinal study conducted in all administrative districts of Bavaria. Participants from both urban and rural areas are included. Participants are people with mild cognitive impairment (MCI) and people with mild to moderate dementia (defined according to ICD-10: F06.7, F00-F03) who are cared for at home by their family caregivers, as well as the family caregivers themselves.
Prior to study enrollment, participants with cognitive impairments are assessed for their suitability for the study using brief cognitive tests (Mini Mental State Examination, Montreal Cognitive Assessment). Participants are then interviewed at several points in time (baseline, after 6 months, after 12 months, annually) on the basis of standardized, face-to-face interviews. Participation is voluntary. As part of the informed consent process, participants will be informed about the project in advance and asked to consent to participate in the study.
Participants are recruited in all administrative districts in Bavaria. Participants are recruited and surveyed through institutions that are active in counseling, care, diagnosis, treatment, and care for people with dementia, including counseling facilities, care groups, and residential communities, as well as outpatient (memory clinics, outpatient care services, general practitioners and specialists), inpatient (acute care hospitals, district clinics, geriatric rehabilitation facilities) and semi-inpatient (geriatric day clinics, day care facilities) institutions.
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Peter L. Kolominsky-Rabas, Univ.-Prof. Dr. med.
- Phone Number: +49 9131 85-35855
- Email: peter.kolominsky-rabas@fau.de
Study Locations
-
-
-
Aschaffenburg, Germany, 63739
- Recruiting
- Klinikum Aschaffenburg-Alzenau
-
Contact:
- Jan Dorr, Dr. med.
- Phone Number: +49 6021 32-3062
- Email: geriatrie@klinikum-ab-alz.de
-
Bad Aibling, Germany, 83043
- Recruiting
- Schön Klinik Bad Aibling
-
Contact:
- Klaus Jahn, Prof. Dr.
- Phone Number: +49 8061 903-0
- Email: kljahn@schoen-klinik.de
-
Bad Neustadt an der Saale, Germany, 97616
- Recruiting
- RHÖN-KLINIKUM Campus Bad Neustadt
-
Contact:
- Renate Weinhardt
- Phone Number: +49 9771 66-24335
- Email: renate.weinhardt@campus-nes.de
-
Bayreuth, Germany, 95445
- Recruiting
- Klinikum Bayreuth
-
Contact:
- Thomas Tümena
- Phone Number: +49 921 400-6680
- Email: thomas.tuemena@klinikum-bayreuth.de
-
Coburg, Germany, 96450
- Recruiting
- Klinikum Coburg, Regiomed Zentrum für Altersmedizin
-
Contact:
- Johannes Kraft, Prof. Dr. med.
- Phone Number: +49 9561 22-7304
- Email: johannes.kraft@klinikum-coburg.de
-
Freyung, Germany, 94078
- Recruiting
- Kliniken Am Goldenen Steig
-
Contact:
- Thomas Motzek-Noé, Dr. med.
- Phone Number: +49 8551 977-1160
- Email: KD@frg-kliniken.de
-
München, Germany, 80335
- Recruiting
- Marion von Tessin Memory-Zentrum
-
Contact:
- Eva Demmel
- Phone Number: +49 89 21 54321-0
- Email: e.demmel@mvt-zentrum.de
-
München, Germany, 80804
- Recruiting
- Schön Klinik München Schwabing
-
Contact:
- Jürgen Herzog, Dr.
- Phone Number: +49 89 36087-132
- Email: jherzog@schoen-klinik.de
-
Neumarkt, Germany, 92318
- Recruiting
- Klinikum Neumarkt
-
Contact:
- Martin Ritt, Prof. Dr. med. habil. Dr. med.
- Phone Number: +49 9181 420-3076
- Email: martin.ritt@klinikum.neumarkt.de
-
Nuremberg, Germany, 90419
- Recruiting
- Klinikum Nürnberg
-
Contact:
- Lea Bräuer
- Phone Number: +49 911 398-3943
- Email: gedaechtnissprechstunde@klinikum-nuernberg.de
-
Regensburg, Germany, 93053
- Recruiting
- Klinik und Poliklinik für Psychiatrie Regensburg
-
Contact:
- Stefan Werner, Dr. med.
- Phone Number: +49 941 941-1221
- Email: gedaechtnis-psy-r@medbo.de
-
Rosenheim, Germany, 83022
- Recruiting
- Böhm-Peters - Praxis für Psychiatrie, Psychotherapie und Neurologie
-
Contact:
- Henning Peters, Dr. Dr. med.
- Phone Number: +49 8031 2213-000
- Email: sbp@kns-rosenheim.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- People with an MMSE score of 24-30 points and an additional MoCA score of 0-23 points
- People with an MMSE score of 15-23 points
- Living in a home environment
- All types of MCI and dementia according to the ICD-10 classification (F06.7, F00-F03)
- Main residence in Bavaria
- All age groups
Exclusion Criteria:
- People with an MMST score of 24-30 points and an additional MoCA score of 24-30 points
- People with an MMST score of 0-14 points
- Permanent residence in a nursing home
- Psychiatric diagnoses (among others depression, schizophrenia, addiction)
- Deafness and/or blindness
- Aphasia
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
People with cognitive impairments
People with mild cognitive impairment and people with dementia
|
|
Family caregivers
Family caregivers of the people with cognitive impairments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gender
Time Frame: Baseline
|
Baseline
|
|
|
Education
Time Frame: Baseline
|
Baseline
|
|
|
Religion
Time Frame: Baseline
|
Baseline
|
|
|
Age
Time Frame: Baseline
|
in years
|
Baseline
|
|
Postal code
Time Frame: Baseline
|
Baseline
|
|
|
Country of birth
Time Frame: Baseline
|
Baseline
|
|
|
Parents' country of birth
Time Frame: Baseline
|
Baseline
|
|
|
Most often spoken language in the household
Time Frame: Baseline
|
Baseline
|
|
|
Vocational training
Time Frame: Baseline
|
Baseline
|
|
|
Employment status
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Marital status
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Number of children
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
in general and those, who live in the same household
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Number of persons living in the household
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Relationship between the person with cognitive impairment and the family caregiver
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Living arrangements
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Which kind of living arrangement (own home environment, assisted living, shared apartment, others) and who are the people, who live in this arrangement (family caregiver, spouse, children, siblings, others)
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Powers of attorney and guardianship
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Existence of a power of attorney for health care, a living will, and legal guardianship (Vorsorgevollmacht, Patientenverfügung, gesetzliche Betreuung)
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Severe disability
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Does a person with cognitive impairments have a severe disability?
(according to German law)
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Name of the health insurance company
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Monthly net income
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
in Euro and in categories (e.g.
0-1000€)
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Use of care leave
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Time of onset of the first symptoms
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
as date
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Dementia diagnosis
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
according to ICD-10
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Time of diagnosis
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
as date
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Age at the time of diagnosis
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Person, who initiated the diagnostic evaluation
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Facility, where the diagnosis was made
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Specialist who made the diagnosis
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Charlson Comorbidity Index (CCI)
Time Frame: Baseline
|
Total Score Range: 0-32 (without dementia), higher values indicate a worse (greater) comorbid disease burden, data collected only at memory-clinics
|
Baseline
|
|
Risk factors
Time Frame: Baseline
|
data collected only at memory-clinics
|
Baseline
|
|
Measures that were used for diagnostic evaluation
Time Frame: Baseline
|
medical history, imaging, laboratory diagnostics, specific measures, data collected only at memory-clinics
|
Baseline
|
|
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Time Frame: Baseline
|
Higher values indicate better cognitive performance, data collected only at memory-clinics
|
Baseline
|
|
Mini Mental State Examination (MMSE)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Total Score Range: 0-30, higher values indicate better cognitive performance
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Montreal Cognitive Assessment (MoCA)
Time Frame: Baseline
|
Total Score Range: 0-30, higher values indicate better cognitive performance
|
Baseline
|
|
Barthel-Index
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Total Score Range: 0-100, higher values indicate better functional independence (less disability)
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Neuropsychiatric Inventory (NPI)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
12 domains, each frequency (1-4) × severity (1-3), Total Score Range: 0-144, higher values indicate worse (more/severe) neuropsychiatric symptoms
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Number of falls requiring treatment in the last six months
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Tendency to wander
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Is the person with cognitive impairment trying to run away from home?
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Resource Utilization in Dementia (RUD)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Dementia Assessment of Service Needs (DEMAND)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
EuroQoL 5D (EQ-5D)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Total Score Range: -0.661 to 1, higher values indicate a better health-related quality of life
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Lubben Social Network Scale (LSNS)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Total Score Range: 0-60, higher values indicate a better social network/less social isolation
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Sources of information on health topics
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Internet, TV/ radio, books, courses and lectures, newspaper and magazines, family, friends and collegues, pharmacies, healthcare professional, others (measured on a Likert scale, from unimportant to very important)
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Last time, the internet was used
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
in categories
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Average internet usage over the past three months
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Devices that were used to access the internet
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Purposes for using the Internet
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Reasons for non-use of the internet
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
|
Mobility
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Possession of a driver's licence and active participation in traffic
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Burden Scale for Family Caregivers (BSFC)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Total Score Range: 0-30, higher values indicate a worse (greater) caregiver burden
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Benefits of Being a Caregiver Scale (BBCS)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Total Score Range: 0-50, higher values indicate a better (more) perceived benefits from caregiving
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
|
Short Form 12 Health Survey (SF-12)
Time Frame: Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Physical health and mental health summary scores, Total Score Range: 0-100, norm based scoring, higher values indicate a better physical/mental health status
|
Baseline, after 6 months, after 12 months, after 24 months, after 36 months, after 48 months, after 60 months, after 72 months, after 84 months, after 96 months, after 108 months, after 120 months
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Dietzel N, Kurten L, Karrer L, Reichold M, Kohler L, Nagel A, Chmelirsch C, Seebahn K, Hladik M, Meuer S, Kirchner A, Holm K, Selau M, Wendel M, Trinkwalter J, Prokosch HU, Graessel E, Kolominsky-Rabas PL. Digital Dementia Registry Bavaria-digiDEM Bayern: study protocol for a multicentre, prospective, longitudinal register study. BMJ Open. 2021 Feb 8;11(2):e043473. doi: 10.1136/bmjopen-2020-043473.
- Reichold M, Dietzel N, Chmelirsch C, Kolominsky-Rabas PL, Graessel E, Prokosch HU. Designing and Implementing an IT Architecture for a Digital Multicenter Dementia Registry: digiDEM Bayern. Appl Clin Inform. 2021 May;12(3):551-563. doi: 10.1055/s-0041-1731286. Epub 2021 Jun 16.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Mental Disorders
- Tauopathies
- Neurodegenerative Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Leukoencephalopathies
- Intracranial Arteriosclerosis
- Intracranial Arterial Diseases
- Alzheimer Disease
- Dementia
- Neurocognitive Disorders
- Dementia, Vascular
Other Study ID Numbers
- 253_20 B
- G42d-G8300-2017/1606-1110 (Other Grant/Funding Number: Bavarian State Ministry of Health, Care and Prevention)
- DRKS00038679 (Registry Identifier: German Clinical Trials Register)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingMCI With Increased Risk for Alzheimer Disease | Alzheimer s DiseaseUnited States
-
Evan ThomasRecruitingDementia | Alzheimer Dementia | Alzheimer Dementia (AD) | Alzheimer s Disease | AlzheimerUnited States
-
University of California, Los AngelesRecruitingAlzheimer Disease | Dementia Alzheimer Type | Alzheimer&Amp;#39;s Disease (AD) | Alzheimer&Amp;Amp;#39;s Disease | Mild Alzheimer&Amp;Amp;#39;s Disease | Moderate Alzheimer&Amp;Amp;#39;s Disease | Alzheimer&Amp;#39;s DementiaUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingAlzheimer s DiseaseChina
-
ChainGen Biopharma LtdChainGen Biopharma (Australia) Pty LtdRecruiting
-
University Hospital, GrenobleRecruiting